Launched in January 2023, the “enhanced Ribosome Innovations” (eRIs) initiative is a public-private experience stemming from the collaboration between the Institute of Biophysics (CNR, Italy) and Immagina Biotechnology s.r.l. eRIs represents a unique milieu that experiments with cutting-edge technologies to develop next-gen solutions and dissect translational landscapes at ultrahigh resolution.
In parallel, eRIs leverages these technologies to discover and develop RNA- and translation-based biomarkers of devastating diseases. eRIs' ultimate mission is to fill the gaps in medical care and counselling practices, meeting and anticipating clinicians and patients’ expectations.
